Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
VBI Vaccines Inc/BC (VBIV)
Sector: Healthcare; Industry: Biotechnology

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology in Israel, the United States, and internationally. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for a functional cure of chronic hepatitis B. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the target virus to elicit a potent immune response. It primarily serves physicians and pharmacists through direct sales. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-04-24 PERCEPTIVE ADVISORS LLC 10%-Owner Buy 9,090,909 $1.10 $10,000,000 No
2019-10-04 Diaz-Mitoma Francisco Chief Medical Officer Buy 54,500 $0.50 $27,250 No
2019-10-01 McNulty Christopher CFO and Head of BD Buy 12,000 $0.47 $5,676 No
2019-10-01 Beattie Nell Chief Business Officer Buy 10,000 $0.48 $4,822 No
2019-09-30 Baxter Jeff CEO, President Buy 150,000 $0.50 $75,450 No
2019-09-23 PERCEPTIVE ADVISORS LLC 10%-Owner Buy 20,000,000 $0.50 $10,000,000 No
2019-06-27 Diaz-Mitoma Francisco Chief Medical Officer Buy 8,000 $1.07 $8,560 No
2019-06-20 Diaz-Mitoma Francisco Chief Medical Officer Buy 52,000 $0.87 $45,180 No
2019-06-18 PERCEPTIVE ADVISORS LLC 10%-Owner Buy 1,000,000 $0.65 $650,000 No
2019-06-19 Beattie Nell Chief Business Officer Buy 8,000 $0.74 $5,886 No
2019-06-19 Baxter Jeff CEO, President Buy 144,000 $0.73 $105,336 No
2019-06-17 PERCEPTIVE ADVISORS LLC 10%-Owner Buy 1,000,000 $0.62 $618,000 No
2018-12-17 Kariv Tomer Director Buy 1,428,571 $1.40 $1,999,999 No
2018-12-13 PERCEPTIVE ADVISORS LLC 10%-Owner Buy 14,285,714 $1.40 $20,000,000 No
2018-08-06 Baxter Jeff CEO, President Buy 8,100 $1.93 $15,607 No
2018-08-03 Diaz-Mitoma Francisco Chief Medical Officer Buy 9,000 $2.13 $19,200 No
2018-08-03 Baxter Jeff CEO, President Buy 13,500 $2.01 $27,111 No
2018-08-03 Beattie Nell Chief Business Officer Buy 2,000 $2.01 $4,011 No
2018-07-31 Baxter Jeff CEO, President Buy 16,800 $2.28 $38,237 No
2018-05-24 Baxter Jeff CEO, President Buy 11,000 $2.99 $32,890 No
2018-05-11 Diaz-Mitoma Francisco Chief Medical Officer Buy 10,000 $3.05 $30,475 No
2018-05-11 Baxter Jeff CEO, President Buy 7,100 $2.91 $20,661 No
2017-12-12 Baxter Jeff CEO, President Buy 10,000 $3.89 $38,854 No
2017-11-28 Baxter Jeff CEO, President Buy 15,000 $4.75 $71,250 No
2017-10-30 Opko Health, Inc. 10%-Owner Buy 655,738 $3.05 $2,000,001 No
2017-10-30 GILLIS STEVEN Director Buy 300,000 $3.05 $915,000 No
2017-10-30 CHAWLA SAM Director Buy 3,100,000 $3.05 $9,455,000 No
2017-10-26 PERCEPTIVE ADVISORS LLC 10%-Owner Buy 3,100,000 $3.05 $9,455,000 No
2017-08-21 Diaz-Mitoma Francisco Chief Medical Officer Buy 3,000 $3.17 $9,510 No
2017-08-21 Baxter Jeff CEO, President Buy 10,000 $3.22 $32,200 No

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.

Insider Smart

PROSPECT CAPITAL CORP (PSEC) - PSEC is the 2nd most bought stock of the past 90 days by insiders, CEO seems very confident about the company.